SA

Suhas Anandrao Kumbhar

Active Director Designated Partner DIN 09518478
DIN 09518478 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Suhas Anandrao Kumbhar

Data last updated:

Suhas Anandrao Kumbhar is a Designated Partner at Vimal Medico Llp (since 2022). The company operates in Pharma.

DIN 09518478
Primary Designation Designated Partner
Industry Pharma
First Appointment 24 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vimal Medico Llp ABA-8009
Designated Partner24 Feb 20222022Active

Board colleagues of Suhas Anandrao Kumbhar

NameDINCompanyDesignation
Sunil Bapusaheb Patil08490612Vimal Medico LlpDesignated Partner
Suraj Suresh Patil09518479Vimal Medico LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vimal Medico Llp
Premium access

Shareholding and investment profile for Suhas Anandrao Kumbhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suhas Anandrao Kumbhar

Suhas Anandrao Kumbhar currently holds 1 directorship: Vimal Medico Llp (Designated Partner, since 24 Feb 2022).

Suhas Anandrao Kumbhar was first appointed on 24 Feb 2022 as Designated Partner at Vimal Medico Llp.

The current boards of Suhas Anandrao Kumbhar's companies include Sunil Bapusaheb Patil (Vimal Medico Llp), Suraj Suresh Patil (Vimal Medico Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available